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Abstract
Background: Blood transfusion is an essential part of healthcare and can improve patient
outcomes. However, like most therapies, it is also associated with significant clinical risks. In
addition, there is some evidence of overuse. Understanding the potential barriers and enablers to
reduced prescribing of blood products will facilitate the selection of intervention components likely
to be effective, thereby reducing the number of costly trials evaluating different implementation
strategies. Using a theoretical basis to understand behaviours targeted for change will contribute
to a 'basic science' relating to determinants of professional behaviour and how these inform the
selection of techniques for changing behaviour. However, it is not clear which theories of behaviour
are relevant to clinicians' transfusing behaviour. The aim of this study is to use a theoretical domains
framework to identify relevant theories, and to use these theories to identify factors that predict
the decision to transfuse.
Methods: The study involves two steps: interview study and questionnaire study. Using a
previously identified framework, we will conduct semi-structured interviews with clinicians to elicit
their views about which factors are associated with waiting and further monitoring the patient
rather than transfusing red blood cells. Interviews will cover the following theoretical domains:
knowledge; skills; social/professional role and identity; beliefs about capabilities; beliefs about
consequences; motivation and goals; memory, attention, and decision processes; environmental
context and resources; social influences; emotion; behavioural regulation; nature of the behaviour.
The interviews will take place independently in Canada and the UK and involve two groups of
physicians in each country (UK: adult and neonatal intensive care physicians; Canada: intensive care
physicians and orthopaedic surgeons). We will: analyse interview transcript content to select
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relevant theoretical domains; use consensus processes to map these domains on to theories of
behaviour; develop questionnaires based on these theories; and mail them to each group of
physicians in the two countries. From our previous work, it is likely that the theories will include:
theory of planned behaviour, social cognitive theory and the evidence-based strategy,
implementation intention. The questionnaire data will measure predictor variables (theoretical
constructs) and outcome variables (intention and clinical decision), and will be analysed using
multiple regression analysis. We aim to achieve 150 respondents in each of the four groups for each
postal survey.
Background
Blood transfusion
Blood transfusion is an essential part of modern health-
care, and can improve patient outcomes. However, like
most therapies, it is also associated with significant clini-
cal risks [1]. It is also a scarce and costly resource [2]. There
is published evidence of variation and suboptimal clinical
transfusion practice in all aspects of transfusion. For
example, there is ongoing evidence of large differences
between hospitals and clinical teams in the use of red cell
transfusions (and other blood products) for the same sur-
gical procedures with no clear explanation based on clin-
ical factors, e.g., pre-operative haemoglobin, peri-
operative blood loss [3]. In a large multicentre study of
Canadian intensive care unit (ICU) patients transfused
over a two-year period, the percentage of patients trans-
fused varied from 20% to 54% across 11 different centres
[4]. A recent regional audit in the UK in patients undergo-
ing primary hip replacement surgery showed a range of
23% to 58% in the proportion of patients who were trans-
fused [2]. The majority of patients who were transfused
received only one or two units of blood, and most were
discharged with a haemoglobin concentration above 10
g/dl. If they had not been transfused, they would still have
had a haemoglobin concentration above 8 g/dl, which
would not be expected to impair postoperative recovery
[5]. Some teams even carry out major procedures without
blood transfusion by attention to patient care throughout
the peri-operative period [6]. The combination of algo-
rithms for blood management and restrictive transfusion
thresholds may in these situations offer a more effective
approach to blood conservation than the implementation
of single interventions such as autologous transfusion [7].
Changing transfusion practice
Variation in the use of blood suggests the potential for a
reduction in blood usage without having a negative
impact on patient care. Many different forms of behaviour
change interventions are used in current clinical practice
by hospitals and blood transfusion services worldwide
with the aim of changing transfusion practice, including
the dissemination of guidelines, retrospective or prospec-
tive audits, educational events, and algorithms for blood
prescribing [8,9]. A systematic review found that all inter-
ventions for the reduction of transfusion studied in clini-
cal trials seemed to be effective, with a reduction in
inappropriate transfusions of 12% to 83% [8] and of 9%
to 77% for the total number of units transfused [9]. How-
ever, there were significant limitations to the quality of
this evidence. Most of the studies were uncontrolled
before-and-after studies that are prone to secular changes,
maturation bias, and bias in favour of the intervention.
Most were single-centre studies, and many were per-
formed more than 10 years ago. The universal success in
the published studies raises the possibility of publication
bias. These concerns about the true effectiveness and the
durability of the effect of these interventions were raised
by one study, which reported a return to the baseline rate
of transfusions three months after the completion of the
intervention, and a follow-up report from another study
[10,11] that reported a return to previous transfusion
practice. Finally, none of the studies formally reported
cost-effectiveness comparisons.
Implementation research
Although the transfer of research findings into practice is
often slow, quality improvement research [12-14] has
demonstrated that interventions can be effective,
although providing less information to guide the choice
or to optimise the components of complex interventions
in actual practice [15]. Hence, there is still a need to study
the influences on healthcare professionals' behaviour and
to design interventions to enable them to use research
findings more effectively. A range of factors (e.g., patient
preference, paucity of solid evidence on which clinicians
can base their decisions, availability of institutional or
jurisdictional protocols or guidelines) may influence
transfusion practice and interventions to change clinical
practice can be aimed at a number of levels (individual
health care professionals, health care groups or teams,
organisations providing health care, the larger health care
system, or environment). While the majority of interven-
tions have been aimed at individual practitioners, the
study described in this protocol will be based on a broad
theoretical framework that includes potential predictors
from models of individual, team-level, and organisational
behaviour. Nevertheless, the outcome to be predicted will
be the behavioural intention and simulated behaviour
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(specific clinical decisions) of individual clinicians, as
ultimately it is the individual clinician who decides much
of the face-to-face health care.
The use of behavioural theory in changing the behaviour of 
healthcare professionals
While the effectiveness of interventions varies across dif-
ferent clinical problems, contexts, and organisations,
studies in general have provided scant theoretical or con-
ceptual rationale for their choice of intervention [16] and
only limited descriptions of the interventions and contex-
tual data.
The UK Medical Research Council (MRC) has proposed a
framework for developing and evaluating complex inter-
ventions [17,18]. The revised framework [18] gives prom-
inence to the development of the intervention, which
includes identifying the evidence base, identifying or
developing theory, and modelling the process or out-
comes. We interpret these three research activities for
implementation research as follows:
1. Identifying the evidence base encompasses two distinct
components in implementation research: verification of
an evidence-practice gap (i.e., would quality of health care
be improved if clinicians' behaviour changed?), and iden-
tification of specific evidence-based behaviour change
techniques ('active ingredients') that are likely to lead to
change.
2. Identifying or developing theory is essential for under-
standing the likely mechanisms of behaviour change. This
informs questions such as how best to deliver and opti-
mise the techniques.
3. Modelling the process or outcomes involves an empiri-
cal investigation by which the theorised pathways that
change or maintain the current behaviour are tested in a
real or simulated clinical context. Results of this investiga-
tion feed back into the evidence base relating to the
behaviour change techniques as well as confirming, dis-
confirming, or developing theory.
The MRC framework thus proposes a systematic, theory-
and evidence-based approach to the identification of the
'active ingredients' for achieving professional behaviour
change. By using a theoretical basis to identify determi-
nants of behaviour and to select behaviour change inter-
ventions, the chances of finding a significant
improvement in response to a specific set of interventions
should increase, thereby reducing the number of costly tri-
als evaluating different implementation strategies. Addi-
tionally, this approach should allow for the combination
of complementary techniques, and possibly identification
of clinical contexts that require different approaches to
target different groups of physicians.
However, this first requires the selection of an appropriate
theoretical framework. A number of psychological theo-
ries have been used to explore the factors associated with
the behaviours of health care practitioners, e.g., the theory
of planned behaviour (TPB) [19] and social cognitive the-
ory [20]. Psychological theories are numerous, and, in
order to rationalise their use, a consensus group of UK
health psychologists derived 12 theoretical 'domains' that
incorporated all relevant theories, and that could be used
to investigate the implementation of evidence-based prac-
tice [21]. A Table reproducing these domains and the the-
oretical constructs they include is shown in Additional
File 1. These theoretical domains offer a comprehensive
list of potentially relevant constructs for the behaviour of
transfusing. They include factors such as local protocols,
management policies, and resources available in the local
context. Based on these constructs, it may be possible to
adopt a systematic approach to selecting appropriate the-
ories.
Clinical Contexts
The target patient groups for this investigation are patients
in ICUs, patients in neonatal intensive care units
(NICUs), and orthopaedic patients (e.g., undergoing sur-
gery for hip fracture). While medical specialties represent
significant users of red blood cells, as a broad generalisa-
tion, transfusion practices in medicine and paediatrics
have been less evaluated by comparison to surgical speci-
alities in audits of transfusion. Within the medical special-
ties, neonates represent a clinical group in which patients
can be heavily exposed to blood and blood components
(i.e., over 90% of extremely low birth weight infants are
treated with blood products) [22], and the risks of blood
(including variant Creutzfeldt-Jakob disease http:en.wiki-
pedia.org/wiki/Creut zfeldt%E2%80%93Jakob_disease)
assume greater significance in view of potential for longer
survival. The evidence base to guide transfusion practice is
strongest in adult critical care, though still incomplete.
The evidence base in neonates is slowly developing, and a
number of recent randomised controlled trials have been
published that, although reporting different findings,
begin to inform and direct behaviour [22,23]. As in adult
intensive care, there is the emergence of over-transfusion
as a problem. In the UK, the PlaNeT study [24], a prospec-
tive cohort of over 150 enrolled severely thrombocyto-
penic neonates and 300 platelet transfusions
administered to nearly 100 neonates at seven different
NICUs in Southern and Eastern England, demonstrated
that most transfused neonates are preterm, but they only
require short term platelet transfusions for prophylaxis.
This study has helped raise the awareness of transfusion
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and created a network of interested neonatologists.
Orthopaedic surgery remains one of the largest users of
red blood cells, as hip and knee replacement surgeries are
relatively common procedures which have a high risk of
anaemia. Yet there is little evidence to guide transfusion
practice in orthopaedic surgery. However, at least one
large randomized controlled trial in hip fracture patients
is underway in the US with expected completion in 2009
[5].
UK and Canadian blood services
The NHS blood and transplant (NHSBT) service is respon-
sible for managing all the products and services, including
promoting blood, tissue, and organ donation to the pub-
lic; managing the supply of blood to hospitals in England
and Wales; and working with hospital staff to promote the
safe and appropriate use of blood. The Canadian Blood
Services (CBS) performs many similar functions for nine
provinces and three territories in Canada. Both the
NHSBT and the CBS work at the hospital, regional, and
national levels to promote appropriate use of blood and
blood products. As such, they are critical partners in the
UK and Canada for the development and testing of inter-
ventions to optimize transfusion practice.
The clinical evidence base to support more restrictive
transfusion practice is fairly new and, to our knowledge,
there have been no investigations of the factors that might
hinder or facilitate change in clinicians' transfusion
behaviour in these clinical contexts. To provide an oppor-
tunity to make cross-country comparisons while investi-
gating a broad range of clinical contexts, we decided to
design parallel studies in two clinical contexts in each
country (Canada and the UK) and to select one clinical
context (adult intensive care) for investigation in both
countries.
Aims and Objectives
The aim of the study is to use constructs from psycholog-
ical theories to identify factors that predict the decision to
transfuse. The objectives are:
1. To conduct semi-structured interviews (based on the
theoretical domains framework) with transfusion pre-
scribers in two clinical contexts in both the UK and Can-
ada, to identify theoretical constructs (and therefore
psychological theories) relevant to the use of red blood
cells.
2. To develop a questionnaire based on the identified the-
ories.
3. To conduct separate postal questionnaire surveys of
intensive/critical care physicians and neonatal physicians
in the UK, and intensive/critical care physicians and
orthopaedic surgeons in Canada.
4. To identify the psychological constructs that, within a
theoretical framework, predict the decision by neonatal
and critical care consultants and orthopaedic surgeons to
transfuse red blood cells (as opposed to continuing to
monitor the patient).
Methods
Clinical setting
We will work with two groups of clinicians in each coun-
try -- intensive/critical care physicians and neonatal physi-
cians in the UK and intensive/critical care physicians and
orthopaedic surgeons in Canada. Physicians in intensive
care are significant users of red blood cells, and there has
been a landmark trial in which mortality was compared in
two groups of patients randomised to receive red cells at a
more or less restrictive haemoglobin trigger threshold
[25,26]. In the UK, there is an evolving network of critical
care physicians across Scotland, Wales, Northern Ireland,
and England who have supported the ATTICS study
(which demonstrated a narrowing but persistent gap in
clinical practice and the evidence for red cell transfusions
in critical care patients) [27-29] in Scotland and the inten-
sive care study of coagulopathy (ISOC) (which described
the current practice of frozen plasma transfusions in criti-
cal care patients [30]) in all four countries. It is expected
that the heightened awareness of transfusion generated
through these studies will facilitate a high response rate to
the questionnaires planned in this survey. Similarly in
Canada, there is a well established critical care research
network (Canadian critical care trials group), which has
carried out much of the seminal work on blood transfu-
sions including the TRICC [26] and TRIPICU [32] trials
evaluating restrictive transfusion triggers in adult and pae-
diatric patients, respectively.
Interview study
We will conduct interviews with clinicians from each clin-
ical area, including physicians at regional centres/aca-
demic/teaching and district/community hospitals.
Although convenience sampling will be used, participants
will also be selected in such a way as to ensure diversity of
age, gender, and hospital size so as to maximise the range
of views expressed. Although the sample will thus not nec-
essarily be representative, we will nevertheless identify a
wide range of views for consideration in the design of the
questionnaire.
The linguistic problem of double negatives makes it quite
difficult to conduct interviews about 'not transfusing.' Pre-
liminary discussions with consultants in the chosen con-
texts established that the alternative to transfusing is
continued monitoring of the patient, or 'watching and
waiting.' Using the previously identified framework [21],
we will therefore ask a series of questions related to the
practice of 'watching and waiting' rather than transfusing
red blood cells. The interview will cover the following
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domains: knowledge; skills; social/professional role and
identity; beliefs about capabilities; beliefs about conse-
quences; motivation and goals; memory, attention, and
decision processes; environmental context and resources;
social influences; emotion; behavioural regulation; nature
of the behaviour. We will not necessarily use these techni-
cal terms but will phrase the issues appropriately for the
clinical context (see Additional File 1).
These interview sessions will be conducted by a trained
interviewer. The sessions will be tape recorded and tran-
scribed for analysis. We anticipate interviewing up to 10
clinicians from each group. The total number of inter-
views will be determined by the time it takes to reach data
saturation such that no further specific beliefs will be
gathered by additional interviews.
The interview transcripts will be analysed in two stages. In
stage one, we will identify all domains in which clinicians
report a wide range of beliefs or in which clinicians report
problems when making the decision to watch and wait
rather than transfuse red cells (This paper is now pub-
lished [33]). A domain will be considered 'relevant' if fre-
quently mentioned responses indicate that it might affect
the decision to transfuse or not. The specific beliefs within
each domain will also be coded. In stage two, the specific
beliefs in each of the relevant domains will be used to
identify constructs in the following manner. Independent
judges will use the list of beliefs (from the stage one anal-
ysis) and a list of constructs included in each theoretical
domain (Additional File 1) to match the beliefs with the
constructs. The identified constructs from the relevant
domains will be discussed by the research team to agree
the theoretical models that represent these constructs. If
the identified constructs represent part of a theory, and are
not represented in other identified theories, then the
entire theory will be included for operationalising in the
questionnaire study.
Questionnaire study
Study design
The predictor variables will be the constructs within the
psychological theories selected in the interview study. The
outcome variables will be behavioural intention and sim-
ulated behaviour for 'watching and waiting instead of
transfusing red blood cells.'
Questionnaire content
Based on the interview study results, we will use the theo-
ries that most clearly represent the construct domains
identified and that can be operationalised in a question-
naire format. From our previous work, it is likely that the
following theories (that have been evaluated in other
health care settings) will be included: the TPB [19], social
cognitive theory [20] and the evidence-based strategy,
implementation intention [34]. These theories have been
examined thoroughly in other health care settings, they
include explanatory factors that are amenable to change,
and they include non-volitional components which
assume that individuals do not always have complete con-
trol over their actions (e.g., the impact of insufficient
financial resources). Table 1 contains examples of the var-
iables within the theories and example questions, and
Additional File 3 shows an example of a finished instru-
ment used for the UK study of intensive care consultants.
Measures
To evaluate behavioural intention (to watch and wait
instead of transfusing red blood cells) and its possible pre-
dictors, the questionnaire will include questions with
multi-item scales to assess elements of the identified psy-
chological theories. Responses will be elicited using a
seven-point Likert scale. The content for these questions
assessing specific beliefs regarding the practice of watch-
ing and waiting rather than transfusing with red blood
cells will be derived from standard practice (e.g., [19,35])
and from the interviews.
Table 1: Examples of likely relevant theories, the variables within the theories, and questionnaire items for the behaviour of managing 
patients with borderline haemoglobin by watching and waiting instead of transfusing red cells.
Theory Predictor Variables Illustrative items
Theory of Planned Behaviour [22] Attitude
Subjective norm (perceived pressure)
Perceived behavioural control; Intention
In general, the benefits of managing patients with borderline 
haemoglobin by watching and waiting instead of transfusing red cells 
outweigh the harms. (Attitude)
Social Cognitive Theory [23] Self-efficacy
Goals relevant to watching and waiting
I am confident that I can manage a patient with borderline 
haemoglobin by watching and waiting instead of transfusing red cells. 
(Self-efficacy)
Implementation Intention [36] Action plan I have a clear plan of how I will manage patients with borderline 
haemoglobin by watching and waiting instead of transfusing red cells.
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We will use three proxy measures of behaviour -- strength
of intention, 'direct estimation' of intention, and simu-
lated behaviour (see Additional File 3).
The questionnaire will measure simulated behaviour. A
number of clinical scenarios will be developed for each
clinical group. The clinical scenarios will use different
combinations of patient characteristics (e.g., diagnosis,
co-morbidities, and laboratory results), and for each sce-
nario, physicians will be asked to report their clinical deci-
sion about whether to transfuse. Examples of scenarios are
attached (Additional File 3).
Sampling procedure
With permission from the relevant professional societies,
we will select a random sample of names from lists of
practising consultants in each country.
Implementation of the postal questionnaires
A covering letter, which will explain the purpose and
nature of the study, will be included with the initial copy
of the questionnaire. The letter will explain the impor-
tance of completing the questionnaire, outline how the
results will be used, and ensure the confidentiality of the
responses. A reminder letter will be sent at week two with
an additional copy of the questionnaire.
Analysis and sample size
The questionnaire data will allow us to assess the relation-
ships between predictor (theoretical constructs) and three
outcome measures (strength of intention, direct estima-
tion of intention, and simulated behaviour). These rela-
tionships will be assessed using multiple regression
analysis. Sample size calculations for the multiple regres-
sion analysis depend on the number of cases per predictor
variable [36]. A minimum sample size of 50 + 8 m is
required, where m is the number of predictor variables
required for the multiple regression analysis. To test indi-
vidual predictors, a sample size of 104 + m is required. We
estimate approximately 12 predictor variables, which will
require 146 respondents to test for multiple correlations,
and 116 to test individual predictor variables. We will aim
to achieve 150 respondents for each of the two surveys in
each country (i.e., 600 respondents in all). Assuming a
response rate of 50%, we will send the questionnaire to
300 consultants in each group. To maximise the response
rate, a customised letter inviting consultants to participate
will be signed by a clinical member of the research team
who is well known within each clinical specialty. As the
consultant groups in each of the countries are close-knit
professional bodies, we expect a high level of support for
this work and thus reasonably high response rates.
Project advisory group
We will establish a project advisory group in each country
that will contain clinical as well as academic representa-
tives and international collaborators. It will meet at inter-
vals dictated by the work.
International comparisons
The studies in the two countries will be run independently
through the steps outlined previously. By using methods
in common, we will have the opportunity to compare
results for physicians working in similar clinical settings
in two different countries, and working in two different
clinical settings within the same country.
We will use multivariate analysis of variance to compare
mean scores on each construct (e.g., to identify any differ-
ences between national or clinical context in intention),
and multiple regression approaches to identify whether
national or clinical context adds to the prediction of
intention and simulated behaviour. Specifically, we will
investigate the following comparisons: intensive care con-
sultants (UK and Canada); intensive care consultants and
orthopaedic surgeons (within Canada); intensive care
consultants and neonatologists (within UK). This will add
an important dimension to the interpretation of the
results of this project as it will enable us to identify
whether relevant domains, theories, and patterns of pre-
diction converge or diverge across different health care
systems and clinical contexts.
Discussion
This study will be based on a theoretical domains frame-
work that is derived from theories of behaviour to identify
relevant theories, and use the theories to predict intention
and simulated behaviour.
Conducting semi-structured interviews (based on the the-
oretical domains framework) to identify theoretical con-
structs (and therefore psychological theories) is an
approach that has rarely been used before, and to our
knowledge has not been used with respect to transfusion
practice. The broad objective of this approach is to
develop an evidence base for selecting theories that are rel-
evant to a particular clinical behaviour in a specific con-
text and that are thus likely to inform the design of studies
seeking to predict or change those behaviours. Although
this is likely to minimise the use of researchers' 'favourite'
theories (whether or not they are relevant), there are
potential pitfalls of this approach. First, if many theories
are potentially relevant, then studies based on them are
likely to become unwieldy and to lack the parsimony that
is scientifically and pragmatically desirable. Second, the
efficiencies gained by using the most relevant theories
may be lost in the time and resources taken to conduct the
kind of interview study proposed here. Nevertheless, we
feel it is worth considering whether a systematic method
for selecting theories is preferable to the use of favourite
theories, or hunches about what might be relevant.
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The questionnaire study will identify the psychological
constructs that predict the decision by clinicians to trans-
fuse red blood cells (as opposed to continuing to monitor
the patient). Identifying the predictors of generalised
intention about transfusing (or not) and simulated behav-
iour (i.e., the decision whether or not to transfuse given a
specific clinical scenario) will inform the development of
interventions to increase evidence-based behaviour in
these clinical contexts. It is therefore important to identify
whether the prediction of intention is an appropriate
basis for interventions to change actual behaviour.
Intention has been defined as 'indications of how hard
people are willing to try, or how much effort they are plan-
ning to exert, in order to perform a behavior' [19]. A pre-
requisite of this approach is that the interim endpoint
(e.g., measure of intention) must be predictive of real
world outcomes. This is the case for behavioural intention
in non-clinical populations as demonstrated by reviews of
both observational and experimental studies. Godin and
Kok [37] reported averaged correlations between inten-
tion and different health-related behaviours ranging from
0.35 to 0.56 (i.e., intention was accounting for between
12% and 31% of the variance in behaviour). Armitage and
Connor [38], from 63 independent studies reporting pro-
spectively measured behavioural data, reported that the
TPB variables that directly influence behaviour (intention
and perceived behavioural control) accounted for a simi-
lar proportion of the variance in behaviour. When behav-
iour measures were self-reported, the TPB accounted for
more of the variance in behaviour than when behaviour
measures were objective or observed. A meta-analysis of
10 meta-analyses by Sheeran [39] reported that intention
accounted for almost one-third of the variance in behav-
iour. Finally, Webb and Sheeran [40] reviewed experi-
mental studies to relate change in intention to change in
behaviour. From meta-analysis of 47 experimental tests of
the intention-behaviour relationship, they concluded that
a 'medium-to-large' change in intention leads to a 'small-
to-medium' change in behaviour. Eccles et al. [41] and
Godin et al. [42] have demonstrated that a similar rela-
tionship is apparent in the smaller number of available
studies of healthcare professional behaviour. These
reviews demonstrate that there is a reliable, but not per-
fect, relationship between stated intention and behaviour.
Considerable research effort has been directed to address-
ing the 'intention-behaviour gap,' and two approaches
have been proposed. One addresses the variability of the
link by focusing on moderators of the intention-behav-
iour relationship, such as intention certainty and attitudi-
nal versus normative control [43,44]. According to this
approach, it is possible to predict which individuals will
enact their intentions (e.g., those whose intentions are
attitudinally controlled). A second approach focuses on
mediators of the intention-behaviour relationship, or
processes that might be regarded as 'post-intentional,'
such as implementation intention [34]. This approach
identifies processes that assist individuals to enact their
intentions, thereby minimising the size of the intention-
behaviour gap. Our approach will allow us to explore
both approaches.
Future work
This study corresponds to specific aspects of the UK's
revised MRC framework for developing complex interven-
tions [18], namely, identifying relevant theory and mod-
elling process and outcome. The results of this project will
be used to develop one or more interventions to change
clinicians' behaviour. These will be piloted and then
tested in a multi-site cluster randomised controlled trial.
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